The global market for SARS-CoV-2 IgG (RBD) ELISA was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for SARS-CoV-2 IgG (RBD) ELISA is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for SARS-CoV-2 IgG (RBD) ELISA is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for SARS-CoV-2 IgG (RBD) ELISA in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of SARS-CoV-2 IgG (RBD) ELISA include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, LOEWE Biochemica, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for SARS-CoV-2 IgG (RBD) ELISA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SARS-CoV-2 IgG (RBD) ELISA.

The SARS-CoV-2 IgG (RBD) ELISA market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global SARS-CoV-2 IgG (RBD) ELISA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the SARS-CoV-2 IgG (RBD) ELISA companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of SARS-CoV-2 IgG (RBD) ELISA Market Report

Report Metric	Details
Report Name	SARS-CoV-2 IgG (RBD) ELISA Market
Segment by Type	ELISA Sets ELISA Kits
Segment by Application	Hospital Clinic Disease control and prevention system
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, LOEWE Biochemica, Shenzhen YHLO Biotech, LG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of SARS-CoV-2 IgG (RBD) ELISA company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the SARS-CoV-2 IgG (RBD) ELISA Market report?

Ans: The main players in the SARS-CoV-2 IgG (RBD) ELISA Market are R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, LOEWE Biochemica, Shenzhen YHLO Biotech, LG

What are the Application segmentation covered in the SARS-CoV-2 IgG (RBD) ELISA Market report?

Ans: The Applications covered in the SARS-CoV-2 IgG (RBD) ELISA Market report are Hospital, Clinic, Disease control and prevention system

What are the Type segmentation covered in the SARS-CoV-2 IgG (RBD) ELISA Market report?

Ans: The Types covered in the SARS-CoV-2 IgG (RBD) ELISA Market report are ELISA Sets, ELISA Kits

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 ELISA Sets

1.2.3 ELISA Kits

1.3 Market by Application

1.3.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Disease control and prevention system

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Perspective (2020-2031)

2.2 Global SARS-CoV-2 IgG (RBD) ELISA Growth Trends by Region

2.2.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Region (2020-2025)

2.2.3 SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Region (2026-2031)

2.3 SARS-CoV-2 IgG (RBD) ELISA Market Dynamics

2.3.1 SARS-CoV-2 IgG (RBD) ELISA Industry Trends

2.3.2 SARS-CoV-2 IgG (RBD) ELISA Market Drivers

2.3.3 SARS-CoV-2 IgG (RBD) ELISA Market Challenges

2.3.4 SARS-CoV-2 IgG (RBD) ELISA Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Revenue

3.1.1 Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Revenue (2020-2025)

3.1.2 Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Players (2020-2025)

3.2 Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by SARS-CoV-2 IgG (RBD) ELISA Revenue

3.4 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio

3.4.1 Global SARS-CoV-2 IgG (RBD) ELISA Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2024

3.5 Global Key Players of SARS-CoV-2 IgG (RBD) ELISA Head office and Area Served

3.6 Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Product and Application

3.7 Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Type

4.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Type (2020-2025)

4.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2026-2031)

5 SARS-CoV-2 IgG (RBD) ELISA Breakdown Data by Application

5.1 Global SARS-CoV-2 IgG (RBD) ELISA Historic Market Size by Application (2020-2025)

5.2 Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America SARS-CoV-2 IgG (RBD) ELISA Market Size (2020-2031)

6.2 North America SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025)

6.4 North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size (2020-2031)

7.2 Europe SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025)

7.4 Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size (2020-2031)

8.2 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2020-2025)

8.4 Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size (2020-2031)

9.2 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025)

9.4 Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size (2020-2031)

10.2 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025)

10.4 Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 R&D Systems

11.1.1 R&D Systems Company Details

11.1.2 R&D Systems Business Overview

11.1.3 R&D Systems SARS-CoV-2 IgG (RBD) ELISA Introduction

11.1.4 R&D Systems Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.1.5 R&D Systems Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Introduction

11.2.4 Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Ortho Clinical Diagnostics

11.3.1 Ortho Clinical Diagnostics Company Details

11.3.2 Ortho Clinical Diagnostics Business Overview

11.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Introduction

11.3.4 Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.3.5 Ortho Clinical Diagnostics Recent Development

11.4 BD Biosciences

11.4.1 BD Biosciences Company Details

11.4.2 BD Biosciences Business Overview

11.4.3 BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Introduction

11.4.4 BD Biosciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.4.5 BD Biosciences Recent Development

11.5 ZEUS Scientific

11.5.1 ZEUS Scientific Company Details

11.5.2 ZEUS Scientific Business Overview

11.5.3 ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Introduction

11.5.4 ZEUS Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.5.5 ZEUS Scientific Recent Development

11.6 Bio-Rad Laboratories

11.6.1 Bio-Rad Laboratories Company Details

11.6.2 Bio-Rad Laboratories Business Overview

11.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Introduction

11.6.4 Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.6.5 Bio-Rad Laboratories Recent Development

11.7 ALPCO

11.7.1 ALPCO Company Details

11.7.2 ALPCO Business Overview

11.7.3 ALPCO SARS-CoV-2 IgG (RBD) ELISA Introduction

11.7.4 ALPCO Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.7.5 ALPCO Recent Development

11.8 Enzo Life Sciences

11.8.1 Enzo Life Sciences Company Details

11.8.2 Enzo Life Sciences Business Overview

11.8.3 Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Introduction

11.8.4 Enzo Life Sciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.8.5 Enzo Life Sciences Recent Development

11.9 BioMérieux

11.9.1 BioMérieux Company Details

11.9.2 BioMérieux Business Overview

11.9.3 BioMérieux SARS-CoV-2 IgG (RBD) ELISA Introduction

11.9.4 BioMérieux Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.9.5 BioMérieux Recent Development

11.10 LOEWE Biochemica

11.10.1 LOEWE Biochemica Company Details

11.10.2 LOEWE Biochemica Business Overview

11.10.3 LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Introduction

11.10.4 LOEWE Biochemica Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.10.5 LOEWE Biochemica Recent Development

11.11 Shenzhen YHLO Biotech

11.11.1 Shenzhen YHLO Biotech Company Details

11.11.2 Shenzhen YHLO Biotech Business Overview

11.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Introduction

11.11.4 Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.11.5 Shenzhen YHLO Biotech Recent Development

11.12 LG

11.12.1 LG Company Details

11.12.2 LG Business Overview

11.12.3 LG SARS-CoV-2 IgG (RBD) ELISA Introduction

11.12.4 LG Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

11.12.5 LG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

R&D Systems

Thermo Fisher Scientific

Ortho Clinical Diagnostics

Shenzhen YHLO Biotech

List of Tables

Table 1. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of ELISA Sets

Table 3. Key Players of ELISA Kits

Table 4. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2020-2025)

Table 8. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2026-2031)

Table 10. SARS-CoV-2 IgG (RBD) ELISA Market Trends

Table 11. SARS-CoV-2 IgG (RBD) ELISA Market Drivers

Table 12. SARS-CoV-2 IgG (RBD) ELISA Market Challenges

Table 13. SARS-CoV-2 IgG (RBD) ELISA Market Restraints

Table 14. Global SARS-CoV-2 IgG (RBD) ELISA Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players (2020-2025)

Table 16. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2024)

Table 17. Ranking of Global Top SARS-CoV-2 IgG (RBD) ELISA Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Headquarters and Area Served

Table 20. Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Product and Application

Table 21. Global Key Players of SARS-CoV-2 IgG (RBD) ELISA, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2020-2025)

Table 25. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Type (2026-2031)

Table 27. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2020-2025)

Table 29. Global SARS-CoV-2 IgG (RBD) ELISA Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global SARS-CoV-2 IgG (RBD) ELISA Revenue Market Share by Application (2026-2031)

Table 31. North America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size by Country (2026-2031) & (US$ Million)

Table 46. R&D Systems Company Details

Table 47. R&D Systems Business Overview

Table 48. R&D Systems SARS-CoV-2 IgG (RBD) ELISA Product

Table 49. R&D Systems Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 50. R&D Systems Recent Development

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific SARS-CoV-2 IgG (RBD) ELISA Product

Table 54. Thermo Fisher Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Ortho Clinical Diagnostics Company Details

Table 57. Ortho Clinical Diagnostics Business Overview

Table 58. Ortho Clinical Diagnostics SARS-CoV-2 IgG (RBD) ELISA Product

Table 59. Ortho Clinical Diagnostics Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 60. Ortho Clinical Diagnostics Recent Development

Table 61. BD Biosciences Company Details

Table 62. BD Biosciences Business Overview

Table 63. BD Biosciences SARS-CoV-2 IgG (RBD) ELISA Product

Table 64. BD Biosciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 65. BD Biosciences Recent Development

Table 66. ZEUS Scientific Company Details

Table 67. ZEUS Scientific Business Overview

Table 68. ZEUS Scientific SARS-CoV-2 IgG (RBD) ELISA Product

Table 69. ZEUS Scientific Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 70. ZEUS Scientific Recent Development

Table 71. Bio-Rad Laboratories Company Details

Table 72. Bio-Rad Laboratories Business Overview

Table 73. Bio-Rad Laboratories SARS-CoV-2 IgG (RBD) ELISA Product

Table 74. Bio-Rad Laboratories Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 75. Bio-Rad Laboratories Recent Development

Table 76. ALPCO Company Details

Table 77. ALPCO Business Overview

Table 78. ALPCO SARS-CoV-2 IgG (RBD) ELISA Product

Table 79. ALPCO Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 80. ALPCO Recent Development

Table 81. Enzo Life Sciences Company Details

Table 82. Enzo Life Sciences Business Overview

Table 83. Enzo Life Sciences SARS-CoV-2 IgG (RBD) ELISA Product

Table 84. Enzo Life Sciences Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 85. Enzo Life Sciences Recent Development

Table 86. BioMérieux Company Details

Table 87. BioMérieux Business Overview

Table 88. BioMérieux SARS-CoV-2 IgG (RBD) ELISA Product

Table 89. BioMérieux Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 90. BioMérieux Recent Development

Table 91. LOEWE Biochemica Company Details

Table 92. LOEWE Biochemica Business Overview

Table 93. LOEWE Biochemica SARS-CoV-2 IgG (RBD) ELISA Product

Table 94. LOEWE Biochemica Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 95. LOEWE Biochemica Recent Development

Table 96. Shenzhen YHLO Biotech Company Details

Table 97. Shenzhen YHLO Biotech Business Overview

Table 98. Shenzhen YHLO Biotech SARS-CoV-2 IgG (RBD) ELISA Product

Table 99. Shenzhen YHLO Biotech Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 100. Shenzhen YHLO Biotech Recent Development

Table 101. LG Company Details

Table 102. LG Business Overview

Table 103. LG SARS-CoV-2 IgG (RBD) ELISA Product

Table 104. LG Revenue in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025) & (US$ Million)

Table 105. LG Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. SARS-CoV-2 IgG (RBD) ELISA Picture

Figure 2. Global SARS-CoV-2 IgG (RBD) ELISA Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Type: 2024 VS 2031

Figure 4. ELISA Sets Features

Figure 5. ELISA Kits Features

Figure 6. Global SARS-CoV-2 IgG (RBD) ELISA Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Disease control and prevention system Case Studies

Figure 11. SARS-CoV-2 IgG (RBD) ELISA Report Years Considered

Figure 12. Global SARS-CoV-2 IgG (RBD) ELISA Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global SARS-CoV-2 IgG (RBD) ELISA Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Region: 2024 VS 2031

Figure 15. Global SARS-CoV-2 IgG (RBD) ELISA Market Share by Players in 2024

Figure 16. Global Top SARS-CoV-2 IgG (RBD) ELISA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SARS-CoV-2 IgG (RBD) ELISA as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by SARS-CoV-2 IgG (RBD) ELISA Revenue in 2024

Figure 18. North America SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2020-2031)

Figure 20. United States SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2020-2031)

Figure 24. Germany SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific SARS-CoV-2 IgG (RBD) ELISA Market Share by Region (2020-2031)

Figure 32. China SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2020-2031)

Figure 40. Mexico SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa SARS-CoV-2 IgG (RBD) ELISA Market Share by Country (2020-2031)

Figure 44. Turkey SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE SARS-CoV-2 IgG (RBD) ELISA Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. R&D Systems Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 48. Thermo Fisher Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 49. Ortho Clinical Diagnostics Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 50. BD Biosciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 51. ZEUS Scientific Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 52. Bio-Rad Laboratories Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 53. ALPCO Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 54. Enzo Life Sciences Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 55. BioMérieux Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 56. LOEWE Biochemica Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 57. Shenzhen YHLO Biotech Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 58. LG Revenue Growth Rate in SARS-CoV-2 IgG (RBD) ELISA Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions